| dc.contributor.author |
Erdogan, Guney |
|
| dc.contributor.author |
Gunaydin, Zeki Yuksel |
|
| dc.contributor.author |
Gurel, Yusuf Emre |
|
| dc.contributor.author |
Kaya, Ahmet |
|
| dc.date.accessioned |
2022-08-17T05:58:08Z |
|
| dc.date.available |
2022-08-17T05:58:08Z |
|
| dc.date.issued |
2014 |
|
| dc.identifier.uri |
http://doi.org/10.5152/akd.2014.5668 |
|
| dc.identifier.uri |
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2460 |
|
| dc.description.abstract |
Axitinib is a novel tyrosine kinase inhibitor which is a second-line
option for the treatment of metastatic renal cell carcinoma with progression after previous therapy (1, 2). We present the first reported case
of acute myocardial infarction in a patient receiving axitinib. |
en_US |
| dc.language.iso |
eng |
en_US |
| dc.publisher |
TURKISH SOC CARDIOLOGYCOBANCESME SANAYI CAD NO 11, NISH ISTANBUL A BLOK KAT 8 NO 47-48, YENIBOSNA, BAHCELIEVLER, ISTANBUL 34196, TURKEY |
en_US |
| dc.relation.isversionof |
10.5152/akd.2014.5668 |
en_US |
| dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
| dc.subject |
Adjuvant systemic therapy was initiated to treat residual metastatic disease |
en_US |
| dc.title |
Peripartum cardiomyopathy associated with triplet pregnancy |
en_US |
| dc.type |
article |
en_US |
| dc.relation.journal |
ANATOLIAN JOURNAL OF CARDIOLOGY |
en_US |
| dc.contributor.department |
Ordu Üniversitesi |
en_US |
| dc.contributor.authorID |
0000-0001-5205-1326 |
en_US |
| dc.contributor.authorID |
0000-0001-9779-7578 |
en_US |
| dc.identifier.volume |
14 |
en_US |
| dc.identifier.issue |
7 |
en_US |
| dc.identifier.startpage |
661 |
en_US |
| dc.identifier.endpage |
662 |
en_US |